A drug from Merck has received FDA approval to expand its use in cervical cancer 

The U.S. Food and Drug Administration on Friday approved the expanded use of Merck & Co’s blockbuster immunotherapy Keytruda in combination with chemoradiation therapy to treat newly diagnosed patients with a common type of cervical cancer.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM